Sarepta Therapeutics Inc
SRPT
ISIN null / Valor 19028527
Sarepta Therapeutics Inc
UMushroom community rating:
About company
Sarepta Therapeutics Inc. is a global biotechnology firm focused on developing precision genetic medicines for rare diseases. The company leverages cutting-edge science in gene therapy, RNA technologies, and gene editing to address conditions that have limited treatment options. Sarepta's approach is characterized by its urgency to develop therapies that can significantly alter the course of diseases by targeting their genetic roots. With a portfolio that spans several advanced platforms, the company aims to provide transformative treatments in areas of high unmet medical need. Sarepta's commitment to innovation in genetic medicine positions it as a key player in the biotech industry, striving to offer hope and tangible solutions to patients facing life-altering diagnoses.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
2285 M
Market cap (USD)
2,298,727
Daily traded volume (Shares)
121.49 / 119.465
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
